Home › Funds › AKRE CAPITAL MANAGEMENT LLC › SOPH

AKRE CAPITAL MANAGEMENT LLC position in SOPH

SOPHIA GENETICS SA · Technology

AKRE CAPITAL MANAGEMENT LLC reported holding 3,719,140 shares of SOPH (SOPHIA GENETICS SA) in its Q3 2026 13F filing — a position valued at US$31.2M, representing 0.81% of its reported portfolio and ranking #12 among its reported holdings. AKRE CAPITAL MANAGEMENT LLC has disclosed SOPH holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)3.72M sh
Reported value held$31.17M
Portfolio Weight0.81%
First reportedQ1 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How AKRE CAPITAL MANAGEMENT LLC's SOPH position evolved

AKRE CAPITAL MANAGEMENT LLC first disclosed a stake in SOPH in Q1 2024 at 287,699 shares (US$1.4M). The position peaked in Q3 2026 at 3,719,140 shares, worth US$31.2M. Across 11 filings, AKRE CAPITAL MANAGEMENT LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 3,719,140 shares valued at US$31.2M. Notable position changes include a 568% increase in Q2 2024 (shares fell 20% over the following quarter), a 66% increase in Q2 2025 (shares rose 54% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 287.70K $1.42M New
Q2 2024 1.92M $8.80M Add
Q3 2024 2.24M $8.17M Add
Q4 2024 2.24M $6.87M Hold
Q1 2025 2.24M $7.43M Hold
Q2 2025 3.72M $11.53M Add
Q3 2025 3.72M $17.70M Hold
Q4 2025 3.72M $17.37M Hold
Q1 2026 3.72M $18.41M Hold
Q2 2026 3.72M $21.46M Hold
Q3 2026 3.72M $31.17M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOPH and 13F data

SOPH (SOPHIA GENETICS SA) is a Technology company. 69 other funds we track also report a position in SOPH — the largest reported positions include GENERATION INVESTMENT MANAGEMENT LLP (US$39.2M), AWM Investment Company, Inc. (US$14.8M), AIGH Capital Management LLC (US$14.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOPH

All SOPH fund holders →

FAQ

How long has AKRE CAPITAL MANAGEMENT LLC held SOPH?

AKRE CAPITAL MANAGEMENT LLC has disclosed SOPH holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is AKRE CAPITAL MANAGEMENT LLC's current position in SOPH?

As of Q3 2026, AKRE CAPITAL MANAGEMENT LLC holds 3.72M shares of SOPH (SOPHIA GENETICS SA), valued at $31.17M, representing 0.81% of its reported portfolio and ranking #12.

Has AKRE CAPITAL MANAGEMENT LLC been buying or selling SOPH?

In the latest 13F filing (Q3 2026), AKRE CAPITAL MANAGEMENT LLC held unchanged its position in SOPH. The position peaked in Q3 2026 at 3.72M shares.

Which other funds hold SOPH?

Other major institutional holders of SOPH include GENERATION INVESTMENT MANAGEMENT LLP, AWM Investment Company, Inc., AIGH Capital Management LLC, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.